Related Experiment Video

Updated: Jul 14, 2026

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

Atypical measles and enhanced respiratory syncytial virus disease (ERD) made simple

Fernando P Polack1

  • 1Department of Pediatrics, Johns Hopkins University School of Medicine Baltimore, MD 21205, USA. fpolack@jhsph.edu

Pediatric Research
|May 23, 2007
PubMed

Insights

Inactivated measles virus (MV) and respiratory syncytial virus (RSV) vaccines caused severe disease upon wild-type exposure due to poor immune responses. Understanding these enhanced diseases is crucial for developing safer, effective vaccines.

Area of Science:

  • Immunology
  • Vaccinology
  • Virology

Background:

  • Inactivated vaccines against measles virus (MV) and respiratory syncytial virus (RSV) led to atypical measles and enhanced respiratory disease (ERD) in the 1960s.
  • These vaccine-induced immune responses lacked protective antibodies and cytotoxic T lymphocyte induction.
  • Post-vaccination exposure resulted in immune complex deposition and a Th2-biased immune response.

Purpose of the Study:

  • To discuss the pathogenesis of atypical measles and ERD.
  • To outline the requirements for generating protective antibodies against MV and RSV.
  • To inform the development of novel, safer, and effective MV and RSV vaccines.

Main Methods:

  • Review of historical data and immunological studies on atypical measles and ERD.
  • Analysis of immune responses, including antibody production, T cell responses, and immune complex formation.
  • Pathogenesis discussion based on observed clinical and immunological findings.

Main Results:

  • Both vaccine types failed to induce long-lived protective immunity.
  • Immune complex deposition and a Th2-skewed immune response were common features.
  • No relapses of atypical measles or ERD were reported, suggesting a different disease course than initial infection.

Conclusions:

  • The pathogenesis of enhanced MV and RSV diseases highlights critical deficiencies in vaccine-induced immunity.
  • Understanding these historical vaccine failures is essential for designing next-generation vaccines.
  • Future vaccine development must focus on eliciting robust, long-lasting protective immune responses against MV and RSV.

More Related Videos

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay09:14

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay

Published on: January 26, 2019

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Coronavirus01:29

Coronavirus

Coronaviruses, including the severe acute respiratory syndrome coronavirus (SARS-CoV), are enveloped viruses characterized by their single-stranded, positive-sense RNA genome and helical nucleocapsid structure. The hallmark of these viruses is their club-shaped spike (S) glycoproteins that protrude from the viral envelope, facilitating attachment to host cells. Typically, coronaviruses infect the upper respiratory tract, often causing mild or asymptomatic disease. However, certain strains like...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Arboviral Encephalitis01:25

Arboviral Encephalitis

Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...